Concerns about methodology and use of 3,5,7-cholestatriene as a marker of oxidative stress Response to "Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients".
King
Annie J
AJ
Priesbe
Teresa J
TJ
D015415:Biomarkers / Q000032:analysis; D002340:Carotid Artery Diseases / Q000473:pathology*; D002782:Cholestenes; D002784:Cholesterol / Q000378:metabolism*; D019411:Clinical Laboratory Techniques; D015986:Confounding Factors, Epidemiologic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004912:Erythrocytes / Q000166:cytology*; D006801:Humans; D015227:Lipid Peroxidation; D008563:Membrane Lipids / Q000737:chemistry*; D018384:Oxidative Stress
C505103:3,5,7-cholestatriene; D015415:Biomarkers; D002782:Cholestenes; D008563:Membrane Lipids; D002784:Cholesterol